✦ LIBER ✦

Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open-label single-arm trial in Korean patients

✍ Scribed by Kyoung Heo; Byung In Lee; Sang Do Yi; Kyoon Huh; Jae Moon Kim; Sang Ahm Lee; Dong Jin Shin; Hong Ki Song; Sang Kun Lee; Jeong Yeon Kim; Sarah Lu; Cécilia Dubois; Françoise Tonner

Book ID: 116880321
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 142 KB
Volume: 16
Category: Article
ISSN: 1059-1311
DOI: 10.1016/j.seizure.2007.02.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Short-term efficacy and safety of zonisa

Short-term efficacy and safety of zonisamide as adjunctive treatment for refractory partial seizures: A multicenter open-label single-arm trial in Korean patients

✍ Kyoung Heo; Byung In Lee; Sang Do Yi; Yong Won Cho; Dong Jin Shin; Hong Ki Song; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 332 KB

Efficacy and safety of pregabalin versus

Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: A randomized, double-blind, noninferiority trial

✍ Zaccara, Gaetano; Almas, Mary; Pitman, Verne; Knapp, Lloyd; Posner, Holly 📂 Article 📅 2014 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 402 KB

0096 An open-label community-based study

0096 An open-label community-based study assessing the efficacy and safety of levetiracetam as adjunctive-therapy in Korean adults with partial epilepsy

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 247 KB

Efficacy and safety of 800 and 1200 mg e

Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures

✍ A. Gil-Nagel; J. Lopes-Lima; L. Almeida; J. Maia; P. Soares-da-Silva; on behalf 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

Long-term safety and efficacy in patient

Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: Results from a phase III open-label extension trial

✍ Aatif Husain; Steve Chung; Edward Faught; Jouko Isojarvi; Cindy McShea; Pamela D 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 395 KB

A single-arm, open-label study of alemtu

A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis

✍ E. J. Fox; H. C. Sullivan; S. K. Gazda; L. Mayer; L. O’Donnell; K. Melia; S. L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 524 KB